TheEdgeResearch
Home / Stocks / TINLY

Teijin Limited (TINLY)

OTC Basic Materials Chemicals - Specialty
$10.66 ▲ +0.00%
Market Cap
$2.06B
Sector
Basic Materials
Industry
Chemicals - Specialty
Beta
0.17
52-Wk Range
7.95-11.6
CEO
Akimoto Uchikawa
Country
JP
Currency
USD

Teijin Limited operates in the Chemicals - Specialty industry of the Basic Materials sector, headquartered in Tokyo, TY, JP. The stock last traded at $10.66, up 0.00% on the session, giving a market capitalisation of $2.06B. On trailing twelve-month figures it carries a trailing P/E of -8.14, a net margin of -4.9%. Its beta of 0.17 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-8.14
Price / Sales
0.40
Price / Book
0.83
EV / EBITDA
-31.92
Gross margin
19.3%
Operating margin
-7.4%
Net margin
-4.9%
Return on equity
Debt / equity
0.78
Current ratio
1.85
Dividend yield
2.8%
Payout ratio
-22.9%
Company profile
Exchange
Other OTC
Employees
15,689
IPO date
1996-11-18
Headquarters
Tokyo, TY, JP
About Teijin Limited

Teijin Limited is a global enterprise actively involved in various sectors, encompassing advanced fibers, films and sheets, composite materials, healthcare, and information technology. Within its materials divisions, the company manufactures a broad array of specialized products. These include high-performance fibers such as aramid and carbon fibers, alongside oxidized PAN fibers and diverse polyethylene-based materials. They also produce various films and sheets, specifically polycarbonate, high-density polyethylene porous films, and general microporous films. Furthermore, Teijin supplies engineering plastics like PC resins and polyphenylene sulfide resins, complete with associated molded components and additives. Their offerings extend to advanced composite solutions, notably lightweight glass and carbon fiber reinforced materials tailored for automotive applications. The materials portfolio is rounded out by polytrimethylene terephthalate products, artificial leather, polyester nanofibers, and sustainable recycled polyester fibers. Teijin's healthcare segment provides a comprehensive range of solutions. This includes pharmaceuticals for various ailments, particularly those affecting bone and joint health, the respiratory system, and cardiovascular and metabolic conditions. They also develop and distribute medical devices, such as home oxygen therapy equipment, non-invasive positive pressure ventilation (NPPV) devices, rehabilitation aids, and systems for sleep-disordered breathing. Other notable healthcare technologies feature a sonic accelerated fracture healing system and a community-based integrated care system. The company's healthcare offerings are further enhanced by orthopedic implantable devices and functional food ingredients. In the realm of information technology, Teijin offers Recopic, an advanced radio-frequency identification (RFID) solution designed for efficient inventory management. Additionally, the company is committed to developing and implementing engineering solutions to address critical global challenges, including environmental pollution, ensuring stable energy supplies, and mitigating the societal impacts of an aging workforce. Established in 1918, Teijin Limited maintains its corporate headquarters in Tokyo, Japan.

Comparable companies

Teijin Limited is most often compared with the following Basic Materials names:

CADLFCHCLYGRGCFKNCAFKNCAYNARRFNWARFSGHIFSGHIYWZZAF
More research on TINLY
TINLY technical analysis TINLY TheEdge Score Compare against peers
Open full interactive analysis & DCF →